Cargando…
The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities
Assuring the quality of medical products manufactured, imported or distributed in francophone sub-Saharan Africa remains a challenge, despite positive signals like the growing engagement in the benchmarking of regulatory authorities and -particularly- in the establishment of the African Medicines Ag...
Autores principales: | Macé, Cécile, Nikiema, Jean-Baptiste, Sarr, Omar Serigne, Ciza Hamuli, Patient, Marini, Roland Djang’eing’a, Neci, Richard Cizungu, Bourdillon Esteve, Pernette, Ravinetto, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557312/ https://www.ncbi.nlm.nih.gov/pubmed/37803394 http://dx.doi.org/10.1186/s40545-023-00628-y |
Ejemplares similares
-
Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
por: Kusynová, Zuzana, et al.
Publicado: (2023) -
Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance
por: Waffo Tchounga, Christelle Ange, et al.
Publicado: (2023) -
Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020) -
Quality of antimalarials in Kinshasa peri-urban areas with regard to local pharmaceutical legislation and regulation
por: Mavungu Landu, Don Jethro, et al.
Publicado: (2019) -
Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab
por: Gnegel, Gesa, et al.
Publicado: (2022)